ReportWire

CLNN Stock Price | Clene Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

[ad_1]

Clene Inc.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.

[ad_2]

Source link